G. Schmitt

1.2k total citations
31 papers, 914 citations indexed

About

G. Schmitt is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, G. Schmitt has authored 31 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 11 papers in Cognitive Neuroscience and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in G. Schmitt's work include Schizophrenia research and treatment (15 papers), Functional Brain Connectivity Studies (9 papers) and Regulation of Appetite and Obesity (6 papers). G. Schmitt is often cited by papers focused on Schizophrenia research and treatment (15 papers), Functional Brain Connectivity Studies (9 papers) and Regulation of Appetite and Obesity (6 papers). G. Schmitt collaborates with scholars based in Germany, France and Switzerland. G. Schmitt's co-authors include Thomas Frodl, Eva Meisenzahl, Johanna Scheuerecker, H.‐J. Möller, Nikolaos Koutsouleris, EM Meisenzahl, M.E. Stoeckel, A Porte, Maximilian F. Reiser and Ronald Bottlender and has published in prestigious journals such as Schizophrenia Research, Cell and Tissue Research and Journal of Psychiatric Research.

In The Last Decade

G. Schmitt

31 papers receiving 896 citations

Peers

G. Schmitt
John R. Kelsoe United States
H.H. Holcomb United States
M.S. Buchsbaum United States
Eileen Kemether United States
Jodi J. Weinstein United States
S C Bakker Netherlands
Mary A. Walker United Kingdom
J.E. Kleinman United States
John R. Kelsoe United States
G. Schmitt
Citations per year, relative to G. Schmitt G. Schmitt (= 1×) peers John R. Kelsoe

Countries citing papers authored by G. Schmitt

Since Specialization
Citations

This map shows the geographic impact of G. Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Schmitt more than expected).

Fields of papers citing papers by G. Schmitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Schmitt. The network helps show where G. Schmitt may publish in the future.

Co-authorship network of co-authors of G. Schmitt

This figure shows the co-authorship network connecting the top 25 collaborators of G. Schmitt. A scholar is included among the top collaborators of G. Schmitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Schmitt. G. Schmitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmitt, G., S. Dresel, Thomas Frodl, et al.. (2011). Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience. 262(3). 183–191. 12 indexed citations
2.
Meisenzahl, Eva, Nikolaos Koutsouleris, Christian Gaser, et al.. (2008). Structural brain alterations in subjects at high-risk of psychosis: A voxel-based morphometric study. Schizophrenia Research. 102(1-3). 150–162. 118 indexed citations
3.
Meisenzahl, Eva, Nikolaos Koutsouleris, Ronald Bottlender, et al.. (2008). Structural brain alterations at different stages of schizophrenia: A voxel-based morphometric study. Schizophrenia Research. 104(1-3). 44–60. 120 indexed citations
4.
Meisenzahl, EM, G. Schmitt, Gerhard Gründer, et al.. (2008). Striatal D2/D3 Receptor Occupancy, Clinical Response and Side Effects with Amisulpride: An Iodine-123-Iodobenzamide SPET Study. Pharmacopsychiatry. 41(5). 169–175. 35 indexed citations
5.
Zetzsche, Dirk Andreas, Ulrich W. Preuss, Thomas Frodl, et al.. (2007). In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: New findings and comparison with the literature. Schizophrenia Research. 96(1-3). 34–45. 19 indexed citations
6.
Scheuerecker, Johanna, Stefan Ufer, Matthew M. Zipse, et al.. (2007). Cerebral changes and cognitive dysfunctions in medication-free schizophrenia – An fMRI study. Journal of Psychiatric Research. 42(6). 469–476. 26 indexed citations
7.
Meisenzahl, EM, G. Schmitt, Johanna Scheuerecker, & H.‐J. Möller. (2007). The role of dopamine for the pathophysiology of schizophrenia. International Review of Psychiatry. 19(4). 337–345. 83 indexed citations
8.
Schmitt, G., Christian la Fougère, S. Dresel, et al.. (2007). Dual-isotope SPECT imaging of striatal dopamine: First episode, drug naïve schizophrenic patients. Schizophrenia Research. 101(1-3). 133–141. 34 indexed citations
9.
Scheuerecker, Johanna, Thomas Frodl, Dirk Andreas Zetzsche, et al.. (2007). Cerebral Differences in Explicit and Implicit Emotional Processing – An fMRI Study. Neuropsychobiology. 56(1). 32–39. 72 indexed citations
10.
Zetzsche, Dirk Andreas, Ulrich W. Preuss, Brigitta Bondy, et al.. (2007). 5‐HT1A receptor gene C −1019 G polymorphism and amygdala volume in borderline personality disorder. Genes Brain & Behavior. 7(3). 306–313. 34 indexed citations
11.
Meisenzahl, Eva, Johanna Scheuerecker, Matthew M. Zipse, et al.. (2006). Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation. European Archives of Psychiatry and Clinical Neuroscience. 256(8). 522–531. 48 indexed citations
12.
Schmitt, G., Thomas Frodl, S. Dresel, et al.. (2005). Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug–naive schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience. 256(2). 115–121. 40 indexed citations
13.
Schmitt, G., EM Meisenzahl, Thomas Frodl, et al.. (2005). The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1. Journal of Psychopharmacology. 19(5). 488–493. 31 indexed citations
14.
Meisenzahl, Eva, Thomas Frodl, Dirk K. Müller, et al.. (2003). Superior temporal gyrus and P300 in schizophrenia: a combined ERP/structural magnetic resonance imaging investigation. Journal of Psychiatric Research. 38(2). 153–162. 25 indexed citations
15.
Schmitt, G., EM Meisenzahl, S. Dresel, et al.. (2002). Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine. Journal of Psychopharmacology. 16(3). 200–206. 21 indexed citations
16.
Weglage, J., G Kurlemann, & G. Schmitt. (1995). Konversionsneurotisches Krankheitsspektrum in der Neuropädiatrie. Klinische Pädiatrie. 207(3). 86–88. 1 indexed citations
17.
Schimchowitsch, Sarah, JoséM. Palacios, M.E. Stoeckel, G. Schmitt, & A Porte. (1986). Absence of Inhibitory Dopaminergic Control of the Rabbit Pituitary Gland Intermediate Lobe. Neuroendocrinology. 42(1). 71–74. 10 indexed citations
18.
Stoeckel, M.E., Sarah Schimchowitsch, J.C. Garaud, et al.. (1983). Immunocytochemical evidence of intragranular acetylation of ?-MSH in the melanotrophic cells of the rabbit. Cell and Tissue Research. 230(3). 511–515. 7 indexed citations
19.
Schmitt, G., M.E. Stoeckel, M. J. Klein, & A Porte. (1982). Effects of experimental hypo-or hypernatremia on the fine structure of the pars intermedia of the murine pituitary. Cell and Tissue Research. 223(3). 641–57. 10 indexed citations
20.
Follénius, E, et al.. (1980). [Melanotropic hormone of goldfish (Carassius auratus L.): radioimmunologic comparison with synthetic alpha-MSH].. PubMed. 291(3). 337–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026